ArticleBrain and behavior2026
Prevalence of Autism Spectrum Disorders and the Years Lived With Disability in Eastern Sub-Saharan Africa, From 1990 to 2023.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutism spectrum disorders are lifelong neurodevelopmental conditions affecting social interaction, communication, and behavior. Despite rising global burden, data from Eastern Sub-Saharan African region are limited. This study estimated the prevalence of ASD and the years lived with disability in the region from 1990 to 2023.
methodsWe analyzed input data from the Global Burden of Diseases 2023 study for the ESSA countries. Prevalence and years lived with disability were estimated using disease modeling with Bayesian meta-regression and spatiotemporal Gaussian process regression. Age-standardized rates were calculated, and 95% uncertainty intervals (UIs) were generated. Trends were assessed for statistical significance based on UIs.
resultsIn 2023, an estimated 4.24 million individuals (95% UI: 2.02, 8.80) were living with ASD in the ESSA region, with an age-standardized prevalence of 814 per 100,000 population (95% UI: 405, 1481). Autism spectrum disorders contributed 0.8 million YLDs (95% UI: 0.3, 1.9), and the age-standardized YLDs rate was 154 per 100,000 population (95% UI: 70, 333). Prevalence and YLDs showed no significant sex or location differences and remained nearly unchanged from 1990 to 2023.
conclusionThe study indicated that ASD is a significant and persistent health burden in the ESSA region, affecting young children and adolescents disproportionately. There is an urgent need for early detection of cases, strengthening collaborative initiatives, and implementing culturally sensitive, community-based interventions to support individuals with ASD and their caregivers. Moreover, improved surveillance and standardized diagnostic practices are important to guide policy and resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.